Rockefeller Capital Management
LCTX icon

Rockefeller Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Rockefeller Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.39K Sell
5,309
-198
-4% -$334 ﹤0.01% 4069
2025
Q4 		$9.2K Buy
5,507
+29
+0.5% +$50 ﹤0.01% 3841
2025
Q3 		$9.26K Buy
+5,478
New +$6.48K ﹤0.01% 3678
2023
Q1 		– Sell
-280
Closed – – 3043
2022
Q4 		$0 Hold
280
– – ﹤0.01% 4055
2022
Q3 		$0 Hold
280
– – ﹤0.01% 4159
2022
Q2 		$0 Buy
+280
New +$369 ﹤0.01% 4265
2020
Q1 		– Sell
-1,100
Closed -$1K – 2430
2019
Q4 		$1K Buy
+1,100
New +$916 ﹤0.01% 1983

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return